Peptide Grading
Research peptide
CJC-1295
From
$29.99
Vendors
14
Lab tested
13 COAs
Key benefits
- GH raised for 6+ days per dose
- IGF-1 up 1.5 to 3 times
- Albumin binding extends half-life
- Restored growth in mice
CJC-1295 is a member of the GHRH analogue family of peptides and consists of a sequence derived from hGRF(1-29). The addition of a DAC group allows for prolonged exposure by binding to albumin compared to native GHRH.
That longer exposure is what makes CJC-1295 interesting in human pharmacology. Studies have followed changes in GH and IGF-1, along with the pharmacokinetic behavior of the DAC form.
At Peptide Grading, CJC-1295 listings can be compared by material form, supplier, reported specifications, COA documentation, quantity, shipping and price per mg.
Typical dose
100-300mcg per injection
2-3 times daily
Route
Subcutaneous
Without DAC: Empty stomach, same timing as ipamorelin. With DAC: Time of day less critical due to long half-life.
Cycle
12-16 weeks
Typical duration
Storage
2-8°C
Follow vendor guidance
Marketplace
Compare all CJC-1295 vendors
Prices per size, coupon codes, lab reports and shipping.
| Vendor | Price | Coupon | Lab test | Shipping | |
|---|---|---|---|---|---|
Biologix Labs 5 mg | $29.99 Lowest price$6.00/mg | Not on file | 2 Days
| Buy | |
Certa Peptides 2 mg | $29.99 $14.99/mg | 1 COA | 1–4 days
| Buy | |
 PepVida Labs 5 mg | $30.00$35.00 −14.3%$6.00/mg | Not on file | 1-3 days
| Buy | |
Vertex Labs 5 mg | $39.00$59.00 −33.9%$7.80/mg | 2 COAs | 3 days
| Buy | |
HLX LABS 5 mg | $39.99 $8.00/mg | 1 COA | 2–5 days
| Buy | |
$39.99 $8.00/mg | Not on file | 1–3 days
| Buy | ||
bioinfinity 5 mg | $45.00 $9.00/mg | 1 COA | 3–5 days
| Buy | |
PRPEPS 10 mg | $45.00 $4.50/mg | Not on file | 2 days
| Buy |
United States, Canada
Switzerland, United Kingdom +29What the evidence shows
CJC-1295 (with DAC) was tested in early human trials in the mid-2000s, which showed long-lasting increases in GH and IGF-1. Clinical development was discontinued, and no later-stage trials were completed.
The constant GH stimulation it produces is different from the natural pulsing pattern, and its long-term effects are unknown.
Safety and regulatory position
Not approved · development stoppedIt is not FDA-approved and is not eligible for routine pharmacy compounding. Short-term studies report flushing, headache, injection-site reactions and water retention. Raising GH and IGF-1 can reduce insulin sensitivity and raise blood sugar, and long-term effects of keeping IGF-1 elevated, including on cancer risk, are not established. Because the DAC version keeps GH raised for days, these effects may last longer than with short-acting peptides. It is prohibited in sport at all times under the WADA list (S2 peptide hormones and growth factors).
Research-grade material sold online is not an approved drug. Its identity, purity and amount can't be assumed without independent testing, so check the vendor's batch COA.
FAQ
Frequently asked questions.
CJC-1295 is a growth hormone-releasing hormone (GHRH) analog available in two forms: with DAC (Drug Affinity Complex) for extended half-life, and without DAC (MOD GRF 1-29) for more pulsatile release. It's one of the most established peptides for growth hormone research.